No Data
No Data
Some May Be Optimistic About Shanghai Hile Bio-Technology's (SHSE:603718) Earnings
The market for Shanghai Hile Bio-Technology Co., Ltd.'s (SHSE:603718) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the founda
Investors in Shanghai Hile Bio-Technology (SHSE:603718) From Three Years Ago Are Still Down 52%, Even After 7.8% Gain This Past Week
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) shareholders know that all too well, since the shar
Hailey Biotech (603718.SH): Net loss of 3.719 million yuan in the first quarter
Gelonghui, April 29丨Hailey Biotech (603718.SH) released its first quarter report. Operating revenue was 70.3 million yuan, down 1.31% year on year, net loss of 3.79 million yuan, net loss of 5.29 million yuan after non-net loss, and basic earnings per share -0.01 yuan.
Individual Investors in Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 13% Last Week
Key Insights Significant control over Shanghai Hile Bio-Technology by individual investors implies that the general public has more power to influence management and governance-related decisions A t
More Unpleasant Surprises Could Be In Store For Shanghai Hile Bio-Technology Co., Ltd.'s (SHSE:603718) Shares After Tumbling 31%
The Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) share price has fared very poorly over the last month, falling by a substantial 31%. Instead of being rewarded, shareholders who have alread
Shanghai Hile Bio-Technology (SHSE:603718) Has Debt But No Earnings; Should You Worry?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
No Data